Shang-Zhong Xu

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Venues

Biomolecules

Expert opinion on drug discovery

PloS one

Nature communications

Hull York Medical School

Fudan University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hull York Medical School

United Kingdom

Reader

Hull York Medical School Jul 01 2008

United Kingdom

Senior lecturer

University of Hull Jul 01 2005 - Jun 06 2008

United Kingdom

Lecturer

University of Leeds Dec 01 2001 - Jun 06 2005

United Kingdom

Research Fellow

Shanghai Xuhui District Central Hospital Dec 12 1996 - Dec 01 1999

China

Consultant Cardiologist, Associate Professor of Medicine

Education History

Fudan University

China

MSC

University of Leeds

United Kingdom

PHD

Publications

Shang-Zhong Xu, Thozhukat Sathyapalan
Molecular Aspects of Cardiovascular Risk Factors. Biomolecules 14 (8) (2024)
Shang-Zhong Xu, Thozhukat Sathyapalan
Molecular Aspects of Cardiovascular Risk Factors. Biomolecules 14 (8) (2024)
Gui-Lan Chen, Bo Zeng, Hongni Jiang, Nikoleta Daskoulidou, Rahul Saurabh, Rumbidzai J Chitando, Shang-Zhong Xu
Ca 2+ Influx through TRPC Channels Is Regulated by Homocysteine-Copper Complexes. Biomolecules 13 (6) (2023)
Gui-Lan Chen, Bo Zeng, Hongni Jiang, Nikoleta Daskoulidou, Rahul Saurabh, Rumbidzai J Chitando, Shang-Zhong Xu
Ca 2+ Influx through TRPC Channels Is Regulated by Homocysteine-Copper Complexes. Biomolecules 13 (6) (2023)
Gui-Lan Chen, Bo Zeng, Hongni Jiang, Nikoleta Daskoulidou, Rahul Saurabh, Rumbidzai J Chitando, Shang-Zhong Xu
Ca 2+ Influx through TRPC Channels Is Regulated by Homocysteine-Copper Complexes. Biomolecules 13 (6) (2023)
Nawel Zaibi, Pengyun Li, Shang-Zhong Xu
Protective effects of dapagliflozin against oxidative stress-induced cell injury in human proximal tubular cells. PloS one 16 (2) (2021)
Dong-Na Su, Shi-Pin Wu, Shang-Zhong Xu
Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis. Stem cell research & therapy 11 (1) (2020)
Chhanda Charan Danta, Andrew N Boa, Sunil Bhandari, Thozhukat Sathyapalan, Shang-Zhong Xu
Recent advances in drug discovery for diabetic kidney disease. Expert opinion on drug discovery 16 (4) (2020)
Pengyun Li, Hussein N Rubaiy, Gui-Lan Chen, Thomas Hallett, Nawel Zaibi, Bo Zeng, Rahul Saurabh, Shang-Zhong Xu
Mibefradil, a T-type Ca2+ channel blocker also blocks Orai channels by action at the extracellular surface. British journal of pharmacology 176 (19) (2019)
Bo Zeng, Gui-Lan Chen, Eliana Garcia-Vaz, Sunil Bhandari, Nikoleta Daskoulidou, Lisa M Berglund, Hongni Jiang, Thomas Hallett, Lu-Ping Zhou, Li Huang, Zi-Hao Xu, Viji Nair, Robert G Nelson, Wenjun Ju, Matthias Kretzler, Stephen L Atkin, Maria F Gomez, Shang-Zhong Xu
ORAI channels are critical for receptor-mediated endocytosis of albumin. Nature communications 8 (1) (2017)

Shang-Zhong Xu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shang-Zhong Xu